No ING1 mutations in human brain tumours but reduced expression in high malignancy grades of astrocytoma

International Journal of Cancer

Volumn 109, Issue 3, 2004, Pages 476-479

  Tallen, Gesche ^a   Kaiser, Ines ^a   Krabbe, Sonja ^a   Lass, Ulrike ^a   Hartmann, Christian ^a   Henze, Günter ^a   Riabowol, Karl ^b   Von Deimling, Andreas ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^b UNIVERSITY OF CALGARY   (Canada)

Author keywords

Brain; Expression; ING1; Mutation; Tumour

Indexed keywords

GAG PROTEIN; INHIBITOR OF GROWTH 1 PROTEIN; ISOPROTEIN; PROTEIN P33; PROTEIN P47; REGULATOR PROTEIN; RNA; UNCLASSIFIED DRUG;

APOPTOSIS; ARTICLE; ASTROCYTOMA; BRAIN TUMOR; CANCER GRADING; CANCER GROWTH; CARCINOGENESIS; CELL CYCLE; CONTROLLED STUDY; CORRELATION ANALYSIS; DNA REPAIR; DNA SEQUENCE; EXON; GENE; GENE EXPRESSION REGULATION; GENE LOCUS; GENE SEQUENCE; HETEROZYGOSITY LOSS; HUMAN; HUMAN CELL; HUMAN TISSUE; ING1 GENE; INTRON; MAJOR CLINICAL STUDY; MUTATIONAL ANALYSIS; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; QUANTITATIVE GENETICS; REGULATORY MECHANISM; SEQUENCE ANALYSIS; TISSUE LEVEL;

ASTROCYTOMA; BRAIN NEOPLASMS; CELL CYCLE PROTEINS; DNA, NEOPLASM; DNA-BINDING PROTEINS; DOWN-REGULATION; EXONS; GENE EXPRESSION REGULATION, NEOPLASTIC; GENES, TUMOR SUPPRESSOR; HUMANS; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; INTRONS; LOSS OF HETEROZYGOSITY; MUTATION; NEOPLASM STAGING; NUCLEAR PROTEINS; PROTEIN ISOFORMS; PROTEINS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; RNA, NEOPLASM; TUMOR SUPPRESSOR PROTEINS;

EID: 1342309544     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/ijc.11715     Document Type: Article

References (30)

1. Garkavtsev I, Kazarov A, Gudkov A, Riabowol K. Suppression of the novel growth inhibitor p33ING1 promotes neoplastic transformation. Nat Genet 1996;14:415-20.
2. Garkavtsev I, Demetrick D, Riabowol K. Cellular localization and chromosome mapping of a novel candidate tumor suppressor gene (ING1). Cytogenet Cell Genet 1997;76:176-8.
3. Maestro R, Piccinin S, Doglioni C, Gasparotto D, Vukosavljevic T, Sulfaro S, Barzan L, Boiocchi M: Chromosome 13q deletion mapping in head and neck squamous cell carcinomas: identification of two distinct regions of preferential loss. Cancer Res 1996;56:1146-50.
4. Dahlen A, Debiec-Rychter M, Pedeutour F, Domanski HA, Hoglund M, Bauer HC, Rydholm A, Sciot R, Mandahl N, Mertens F. Clustering of deletions on chromosome 13 in benign and low-malignant lipomatous tumors. Int J Cancer 2003;103:616-23.
5. Chen L, Matsubara N, Yoshino T, Nagasaka T, Hoshizima N, Shirakawa Y, Naomoto Y, Isozaki H, Riabowol K, Tanaka N. Genetic alterations of candidate tumor suppressor ING1 in human esophageal squamous cell cancer. Cancer Res 2001;61:4345-9.
6. Oki E, Maehara Y, Tokunaga E, Kakeji Y, Sugimachi K. Reduced expression of p33(ING1) and the relationship with p53 expression in human gastric cancer. Cancer Lett 1999;147:157-62.
7. Toyama T, Iwase H, Watson P, Muzik H, Saettler E, Magliocco A, DiFrancesco L, Forsyth P, Garkavtsev I, Kobayashi S, Riabowol K. Suppression of ING1 expression in sporadic breast cancer. Oncogene 1999;18:5187-93.
8. Gunduz M, Ouchida M, Fukushima K, Hanafusa H, Etani T, Nishioka S, Nishizaki K, Shimizu K. Genomic structure of the human ING1 gene and tumor-specific mutations detected in head and neck squamous cell carcinomas. Cancer Res 2000;60:3143-6.
9. Feng X, Hara Y, Riabowol K. Different HATS of the ING1 gene family. Trends Cell Biol 2002;12:532-8.
10. Collins VP. Gliomas. Cancer Surv 1998;32:37-51.
11. Henson JW, Schnitker BL, Correa KM, von Deimling A, Fassbender F, Xu H-J, Benedict WF, Yandell DW, Louis DN. The retinoblastoma gene is involved in malignant progression of astrocytomas. Annals of Neurology 1994;36:714-21.
12. Bijlsma EK, Voesten AM, Bijleveld EH, Troost D, Westerveld A, Merel P, Thomas G, Hulsebos TJ. Molecular analysis of genetic changes in ependymomas. Genes Chromosomes Cancer 1995;13:272-7.
13. Wooten EC, Fults D, Duggirala R, Williams K, Kyritsis AP, Bondy ML, Levin VA, O'Connell P. A study of loss of heterozygosity at 70 loci in anaplastic astrocytoma and glioblastoma multiforme with implications for tumor evolution. Neuro-oncol 1999;1:169-76.
14. Hara Y, Zheng Z, Evans SC, Malatjalian D, Riddell DC, Guernsey DL, Wang LD, Riabowol K, Casson AG. ING1 and p53 tumor suppressor gene alterations in adenocarcinomas of the esophagogastric junction. Cancer Lett 2003;192:109-16.
15. Aasland R, Gibson TJ, Stewart AF. The PHD finger: implications for chromatin-mediated transcriptional regulation. Trends Biochem Sci 1995;20:56-9.
16. Scott M, Bonnefin P, Vieyra D, Boisvert FM, Young D, Bazett-Jones DP, Riabowol K. UV-induced binding of ING1 to PCNA regulates the induction of apoptosis. J Cell Sci 2001;114:3455-62.
17. Kleihues P, Cavenee WK. Pathology and genetics of tumours of the nervous system, ed. 1. Lyon: IARC Press, 2000.
18. Tokunaga E, Maehara Y, Oki E, Kitamura K, Kakeji Y, Ohno S, Sugimachi K. Diminished expression of ING1 mRNA and the correlation with p53 expression in breast cancers. Cancer Lett 2000;152:15-22.
19. Ohmori M, Nagai M, Tasaka T, Koeffler HP, Toyama T, Riabowol K, Takahara J. Decreased expression of p33ING1 mRNA in lymphoid malignancies. Am J Hematol 1999;62:118-9.
20. Boland D, Olineck V, Bonnefin P, Viéyra D, Parr E, Riabowol K. A panel of CAb antibodies recognize endogenous and ectopically expressed ING1 protein. Hybridoma 2000;19:161-5.
21. Skowyra D, Zeremski M, Neznanov N, Li M, Choi Y, Uesugi M, Hauser CA, Gu W, Gudkov AV, Qin J. Differential association of products of alternative transcripts of the candidate tumor suppressor ING1 with the mSin3/HDAC1 transcriptional corepressor complex. J Biol Chem 2001;276:8734-9.
22. Nouman GS, Anderson JJ, Mathers ME, Leonard N, Crosier S, Lunec J, Angus B. Nuclear to cytoplasmic compartment shift of the p33ING1b tumour suppressor protein is associated with malignancy in melanocytic lesions. Histopathology 2002;40:360-6.
23. Merlo A, Herman JG, Mao L, Lee DJ, Gabrielson E, Burger P, Baylin PC, Sidransky D. 5-prime CpG island methylation is associated with transcriptional silencing of the tumour suppressor p16/CDKN2/MTS1 in human cancers. Nature Med 1995;1:686-92
24. Garkavtsev I, Grigorian IA, Ossovskaya VS, Chernov MV, Chumakov PM, Gudkov AV. The candidate tumour suppressor p33ING1 cooperates with p53 in cell growth control. Nature 1998;391:295-8.
25. Leung KM, Po LS, Tsang FC, Siu WY, Lau A, Ho HT, Poon RY. The candidate tumor suppressor ING1b can stabilize p53 by disrupting the regulation of p53 by MDM2. Cancer Res 2002;62:4890-3.
26. Vieyra D, Toyama T, Hara Y, Boland D, Johnston R, Riabowol K. ING1 isoforms differentially affect apoptosis in a cell age-dependent manner. Cancer Res 2002;62:4445-52.
27. von Deimling A, Fimmers R, Schmidt MC, Bender B, Fassbender F, Nagel J, Jahnke R, Kaskel P, Duerr E-M, Koopmann J, Maintz D, Steinbeck S, et al. Comprehensive allelotype and genetic analysis of 466 human nervous system tumors. J Neuropathol Exp Neurol 2000;59:544-58.
28. Lafuente JV, Alkiza K, Garibi JM, Alvarez A, Bilbao J, Figols J, Cruz-Sanchez FF. Biologic parameters that correlate with the prognosis of human gliomas. Neuropathology 2000;20:176-83.
29. Vieyra D, Loewith R, Scott M, Bonnefin P, Boisvert FM, Cheema P, Pastyryeva S, Meijer M, Johnston RN, Bazett-Jones DP, McMahon S, Cole MD, et al. Human ING1 proteins differentially regulate histone acetylation. J Biol Chem 2002;277:29832-9.
30. Louis DN, von Deimling A, Seizinger BR. A (CA)n dinucleotide repeat assay for evaluating loss of allelic heterozygosity in small and archival human brain tumor specimens. Am J Pathol 1992;141:777-82.